D-Gluconic acid,2,4:2',4'-O-(oxydistibylidyne)bis-, sodium salt, hydrate (1:3:9) cas no:16037-91-5
Synonyms: D-Gluconicacid, 2,4:2',4'-O-(oxydistibylidyne)bis-, Sb,Sb'-dioxide, trisodium salt,nonahydrate;D-Gluconic acid, 2,4:2',4'-O-[oxybis(oxidostibylidyne)]bis-,trisodium salt, nonahydrate (9CI);Solustibosan (7CI);1,3,2-Dioxantimonane,D-gluconic acid deriv.;1,3,2-Dioxastibinane, D-gluconic acid deriv.;Antimony sodiumgluconate;D-Gluconic acid, cyclic ester with antimonic acid (H8Sb2O9) (2:1),trisodium salt, nonahydrate;Myostibin;Pentostam;Sodium stibogluconate;Solustin;Solusurmin;Solyusurmin;Stibanate;Stibanose;Stibatin;Stibinol;Stibogluconate sodium;
NameD-Gluconic acid,2,4:2',4'-O-(oxydistibylidyne)bis-, sodium salt, hydrate (1:3:9)
CAS16037-91-5
SynonymsD-Gluconicacid, 2,4:2',4'-O-(oxydistibylidyne)bis-, Sb,Sb'-dioxide, trisodium salt,nonahydrate;D-Gluconic acid, 2,4:2',4'-O-[oxybis(oxidostibylidyne)]bis-,trisodium salt, nonahydrate (9CI);Solustibosan (7CI);1,3,2-Dioxantimonane,D-gluconic acid deriv.;1,3,2-Dioxastibinane, D-gluconic acid deriv.;Antimony sodiumgluconate;D-Gluconic acid, cyclic ester with antimonic acid (H8Sb2O9) (2:1),trisodium salt, nonahydrate;Myostibin;Pentostam;Sodium stibogluconate;Solustin;Solusurmin;Solyusurmin;Stibanate;Stibanose;Stibatin;Stibinol;Stibogluconate sodium;
Molecular FormulaC12H20 O17 Sb2 . 9 H2 O . 3 Na
Molecular Weight1048.91
storage temp2-8°C
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(b)
Safety
Poison by intraperitoneal route. See also ANTIMONY COMPOUNDS. When heated to decomposition it emits toxic fumes of Sb.
RIDADR 3282
WGK Germany 3
RTECS CC7930000
HazardClass 6.1(b)
PackingGroup III
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
33mg/kg (33mg/kg) |
|
Compilation of LD50 Values of New Drugs. |
mouse |
LD50 |
subcutaneous |
7747mg/kg (7747mg/kg) |
|
Indian Journal of Pharmacy. Vol. 11, Pg. 155, 1949. |
mouse |
LD50 |
unreported |
1625mg/kg (1625mg/kg) |
|
Drugs of the Future. Vol. 18, Pg. 451, 1993. |